Blog

BASi Returns to Q2 Profit

West Lafayette-based Bioanalytical Systems Inc. (Nasdaq: BASI) has announced a fiscal second quarter net income of more than $150,000, compared to a loss of $219,000 during the same quarter last year. Chief Executive Officer Jacqueline Lemke says the pharmaceutical development company has “intensified” its business recruitment efforts.

Leave a Comment

Name*

Email* (never published)

Website